Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Russell, Meyers"'
Autor:
David T. Huang, Erin K. McCreary, J. Ryan Bariola, Richard J. Wadas, Kevin E. Kip, Oscar C. Marroquin, Stephen Koscumb, Kevin Collins, Judith A. Shovel, Mark Schmidhofer, Mary Kay Wisniewski, Colleen Sullivan, Donald M. Yealy, Meredith Axe, David A. Nace, Ghady Haidar, Tina Khadem, Kelsey Linstrum, Graham M. Snyder, Christopher W. Seymour, Stephanie K. Montgomery, Bryan J. McVerry, Lindsay Berry, Scott Berry, Russell Meyers, Alexandra Weissman, Octavia M. Peck-Palmer, Alan Wells, Robert Bart, Debbie L. Albin, Tami Minnier, Derek C. Angus
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Abstract Objectives The primary objective is to evaluate the comparative effectiveness of COVID-19 specific monoclonal antibodies (mABs) with US Food and Drug Administration (FDA) Emergency Use Authorization (EUA), alongside UPMC Health System effort
Externí odkaz:
https://doaj.org/article/11a244af7e12486d9480802ecb95cd0a
Autor:
Erin K, McCreary, Kevin E, Kip, Kevin, Collins, Tami E, Minnier, Graham M, Snyder, Ashley, Steiner, Russell, Meyers, Tina, Borneman, Michelle, Adam, Lauren, Thurau, Donald M, Yealy, David T, Huang, J Ryan, Bariola, Mark, Schmidhofer, Richard J, Wadas, Derek C, Angus, Paula L, Kip, Oscar C, Marroquin
Publikováno v:
Open Forum Infectious Diseases. 9
Background Monoclonal antibody (mAb) treatment is associated with decreased risk of hospitalization and death in high-risk outpatients with mild to moderate coronavirus disease 2019 (COVID-19) caused by early severe acute respiratory syndrome coronav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ef9e71898eae8fa560798fb9f5abcc
https://doi.org/10.1093/ofid/ofac517
https://doi.org/10.1093/ofid/ofac517
Autor:
Erin K. McCreary, J. Ryan Bariola, Richard J. Wadas, Judith A. Shovel, Mary Kay Wisniewski, Michelle Adam, Debbie Albin, Tami Minnier, Mark Schmidhofer, Russell Meyers, Oscar C. Marroquin, Kevin Collins, William Garrard, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Kelsey Linstrum, Anna Nakayama, Stephanie K. Montgomery, Graham M. Snyder, Donald M. Yealy, Derek C. Angus, Paula L. Kip, Christopher W. Seymour, David T. Huang, Kevin E. Kip
Publikováno v:
JAMA network open. 5(4)
Monoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19; however, only intravenous administration has been evaluated in randomized clinical trials of treatment. Subcutaneous admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5777f6a40b54f37e8216db7d53d7ae6
https://pubmed.ncbi.nlm.nih.gov/35412625
https://pubmed.ncbi.nlm.nih.gov/35412625
Autor:
Erin K. McCreary, J. Ryan Bariola, Tami E. Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Kevin E. Kip, Kevin Collins, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyers, Alexandra Weissman, William Garrard, Octavia M. Peck-Palmer, Alan Wells, Robert D. Bart, Anne Yang, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Tina Khadem, Kelsey Linstrum, Stephanie K. Montgomery, Daniel Ricketts, Jason N. Kennedy, Caroline J. Pidro, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Donald M. Yealy, Derek C. Angus, Anna Nakayama, Rachel L. Zapf, Paula L. Kip, Christopher W. Seymour, David T. Huang
Publikováno v:
Contemporary clinical trials. 119
Monoclonal antibodies (mAb) that neutralize SARS-CoV-2 decrease hospitalization and death compared to placebo in patients with mild to moderate COVID-19; however, comparative effectiveness is unknown. We report the comparative effectiveness of bamlan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9320c893865a47ef9207e5721f0dc1f4
https://pubmed.ncbi.nlm.nih.gov/35697146
https://pubmed.ncbi.nlm.nih.gov/35697146
Autor:
Richard J. Wadas, Mary Kay Wisniewski, Lindsay R. Berrry, Scott M. Berry, Anna McGlothlin, Anna Nakayama, Christopher W. Seymour, Judith A Shovel, Donald M. Yealy, Mark Schmidhofer, Erin K McCreary, Kevin E. Kip, Tami Minnier, Stephanie K. Montgomery, Derek C. Angus, David T. Huang, Kelsey Linstrum, William Garrard, Paula L Kip, Oscar C. Marroquin, Debbie Albin, Kevin Collins, Michelle Adam, Graham M. Snyder, Russell Meyers, Amy M. Crawford, J Ryan Bariola
ImportanceMonoclonal antibody (mAb) treatment decreases hospitalization and death in outpatients with mild to moderate COVID-19; however, only intravenous administration has been evaluated in randomized clinical trials of treatment. Subcutaneous admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d9b8ba79e9a9f2e325d1ad2e5b301ba
https://doi.org/10.1101/2021.11.30.21266756
https://doi.org/10.1101/2021.11.30.21266756
Autor:
David T. Huang, Erin K. McCreary, J. Ryan Bariola, Tami E. Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Kevin E. Kip, Kevin Collins, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyers, Alexandra Weissman, William Garrard, Octavia M. Peck-Palmer, Alan Wells, Robert D. Bart, Anne Yang, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Tina Khadem, Kelsey Linstrum, Stephanie K. Montgomery, Daniel Ricketts, Jason N. Kennedy, Caroline J. Pidro, Anna Nakayama, Rachel L. Zapf, Paula L. Kip, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Donald M. Yealy, Derek C. Angus, Christopher W. Seymour
Publikováno v:
JAMA Network Open. 5:e2220957
The effectiveness of monoclonal antibodies (mAbs), casirivimab-imdevimab and sotrovimab, is unknown in patients with mild to moderate COVID-19 caused by the SARS-CoV-2 Delta variant.To evaluate the effectiveness of mAb against the Delta variant compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d5231009367bc2c7a314166ec149dd
https://doi.org/10.1001/jamanetworkopen.2022.20957
https://doi.org/10.1001/jamanetworkopen.2022.20957
Autor:
Kelsey Linstrum, Ghady Haidar, David A. Nace, Russell Meyers, Stephanie K. Montgomery, Donald M. Yealy, Lindsay R. Berry, Colleen Sullivan, Richard J. Wadas, Tami Minnier, Kevin E. Kip, Meredith Axe, Alexandra Weissman, J Ryan Bariola, Robert Bart, Mark Schmidhofer, Octavia M Peck-Palmer, Mary Kay Wisniewski, Debbie Albin, Derek C. Angus, Alan Wells, David T. Huang, Christopher W. Seymour, Graham M. Snyder, Bryan J. McVerry, Judith A Shovel, Tina Khadem, Erin K McCreary, Stephen Koscumb, Kevin Collins, Oscar C. Marroquin, Scott M. Berry
Publikováno v:
Trials
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Objectives The primary objective is to evaluate the comparative effectiveness of COVID-19 specific monoclonal antibodies (mABs) with US Food and Drug Administration (FDA) Emergency Use Authorization (EUA), alongside UPMC Health System efforts to incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd8dc26905392b161b2adc721cf055f1
https://doi.org/10.1186/s13063-021-05316-3
https://doi.org/10.1186/s13063-021-05316-3
Autor:
Erin K. McCreary, J. Ryan Bariola, Tami Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyers, Tina Khadem, William Garrard, Kevin Collins, Alan Wells, Robert D. Bart, Kelsey Linstrum, Stephanie K. Montgomery, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Christopher W. Seymour, Donald M. Yealy, David T. Huang, Derek C. Angus
Publikováno v:
Contemporary Clinical Trials
Outpatient treatments that limit progression to severe coronavirus disease 2019 (COVID-19) are of vital importance to optimise patient outcomes and public health. Monoclonal antibodies (mAb) demonstrated ability to decrease hospitalizations in random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e73a31577d98adf547ad249060bbc7e7
http://europepmc.org/articles/PMC8654455
http://europepmc.org/articles/PMC8654455
Autor:
Russell Meyers
Publikováno v:
Developmental Medicine & Child Neurology. 6:565-572
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9219f13800c6f27c12856bf8fa0acd8
https://doi.org/10.1111/j.1469-8749.1964.tb02794.x
https://doi.org/10.1111/j.1469-8749.1964.tb02794.x
Autor:
Russell Meyers, Zhiyuan Li
Publikováno v:
Languages and Compilers for Parallel Computing ISBN: 9783540897392
LCPC
LCPC
Conventional iterative solvers for partial differential equations impose strict data dependencies between each solution point and its neighbors. When implemented in OpenMP, they repeatedly execute barrier synchronization in each iterative step to ens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbc2f85e6a7d3b46e59b97faab80077b
https://doi.org/10.1007/978-3-540-89740-8_20
https://doi.org/10.1007/978-3-540-89740-8_20